Fotemustine in Treating Patients With Metastatic Melanoma

Clinical trial NCT00560118 · TERMINATED

Trial details

NCT number: NCT00560118
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2003-08-08
Primary completion: 2008-08-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.